Anatomía Patológica
Inmunohistoquímica diagnóstica en metástasis ováricas
Referencias
1-Lash RH,Hart WR. Intestinal adenocarcinomas metastatic to the ovaries. A clicopathologic evaluation of 22 cases. Am J Surg Patol 1987; 11: 114-121.
2-McCluggage WG. Recent advances in immunohistochemistrry in the diagnosis of ovarian neoplasms. J Clin Pathol 2000; 53: 558-560.
3-Joshi VV. Primary Krukemberg tumor of ovary. Review of the literature and case report. Cancer 1968; 22: 1199-1207.
4-Mrad K, Morice P, Febre A, Pautier P, y col. Krukemberg tumor: a clinicopathologic study of 15 cases. Ann Pathol 2000; 20: 202-206.
5-Vang R, Bague S, Tavassoli FA, Prat J. Signet-ring stromal tumor of the ovary: clinicopathologic analysis and comparison with Krukemberg tumor. Int J Gynecol Pathol 2004; 23: 45-51.
6-Suarez A, Palacios J, Burgos E, Gamallo C. Signet-ring stromal tumor of the ovary: a histochemical, immunohistochemical and ultrastructural study. Virchows Arch A Pathol Anat Histopathol 1993; 422: 333-325.
7-Bullon A, Arseneau J, Prat J, Young RH, Scully RE. Tubular Krukemberg tumor. A problem in histopathologic diagnosis. Am J SurgPathol 1981; 5: 225-232.
8-Prat J, Morice P. Secondary Tumors of the ovary. Tumours of the breast and female organs. In Pathology & Genetics. WHO Classification of Tumours. Tavassoli FE & Devilee P. Edits. IARC Press, Lyon, 2003; 193-196.
9- García Tamayo J, Hernádez C. La inmunohistoquímica en el cáncer metastásico. En Vital-Academia Biomédica digital, http://caibco.ucv.ve/Vitae/Vitae Catorce. Enero-marzo, 2002
10- Deavers MT, Malpica A, Liu J, Broaddus R, Silva EG. Ovarian sex cord-stromal tumors: an immunohistochemical study including a comparison of calretinin and inhibin. Mod Pathol 2003; 16 :584-590.
11-Movahedi-Lankarani S, Kurman R J. Calretinin, a more sensitive but less specific marker than alpha-inhibin for ovarian sex cord-stromal neoplasms. An immunohistochemical study of 215 cases. Am J Surg Pathol 2002; 26 :1477-1483.
12- Berezoswski K, Stastny JF, Kornstein MJ. Cytokeratins 7 and and 20 and carcinoembryonic antigen in ovarian and colonic carcinoma. Mod Pathol 1995; 9: 426-429.
13- Chu PG, Wu E, Weiss LM. Cytokeratin 7 and cytokeratin 20 expression in epithelial neoplasms: a survey of 435 cases. Mod Pathol 2000; 13: 962-972.
14-Park SO, Kim HS, Hong eK, Kim AWH. Expression of cytokeratin 7 and 20 in primary carcinomas of the stomach and colorectum and their value in the differential diagnosis of metastatic carcinomas of the ovary. Human Pathol 2002; 33: 1078-1085.
15-Birnkrant A, Sampson J, Sugarbaker PH. Ovarian metastases from colorectal cancer. Dis Colon Rectum 1986; 29: 767-771
16-Seidman JD, Kurman RJ, Ronnett BM. Primary and metastatic mucinous adenocarcinomas in the ovaries: incident in routine practice with a new approach to improve intraoperative diagnosis. Am J Surg Pathol 2003; 27: 985-993.
17-Lee KR, Young RH. The distinction between primary and metastatic mucinous carcinoma in the ovary. Gross and histologic findings in 50 cases. Am J Surg Pathol 2003; 27: 281-292.
18-Vang R, Ronnett BM. Distinction of primary ovarian mucinous tumors and mucinous tumors metastatic to the ovary. A practical approach with guidelines for prediction of primary site for metastases of uncertain origin. Pathology Case Reviews 2006; 11: 18-30.
19- Loy TS, Calaluce RD, Kenney GL. Cytokeratin immunostaining in differentiating primary ovarian carcinoma from metastatic colonic adenocarcinoma. Mod Pathol 1996; 1: 1040-1044.
20-Berezowski K, Stantny JF, Kornstein MJ. Cytokeratin 7 and 20 and carcinoembryonic antigen in ovarian and colonic carcinoma. Mod Pathol 1996; 9: 426-429.
21-Ji H, Isacson C, Seidman JD, Kurman RJ, Ronnett BM. Cytokerantin 7 and 20, Dpc4 and MUC5AC in the distinction of metastatic carcinoma mucinous carcinomas in the ovary from primary ovarian mucinous tumors: Dpc4 assists in identifying metastatic pancreatic carcinomas. Int J Gynecol Pathol 2002; 21: 391-400.
22- Palacios J, Gamallo C. Mutations in the β-catenin gene (CTNNB1) in endometrioid ovarian carcinomas. Cancer Res 1998; 58: 1344-1347.
23-Chou YY, Jen YM, Kao HL, Chen T, Mao TL, Lin MC. Differentiation of ovarian mucinous carcinoma and metastatic colorectal adenocarcinoma by immunostaining with β-catenin. Histopathology 2003; 43: 151-153.
24-Ronnet BM, Kurman RJ, Shmookler BM, Sugarbaker PH, Young RH. The morphologic spectrum of ovarian metastases of appendiceal adenocarcnomas: a clinicopathologic and immunohistochemical analysis of tumors often misinterpreted as primary ovarian tumors or metastatic tumors from other gastrointestinal sites. Am J Surg Pathol 1997; 21:1144-1155.
25-Ronnet BM, Kurman RJ, Zahn CM y col. Pseudomyxoma peritonei in woman: a clinicopathologic analysis of 30 cases with emphasis on site of origin, prognosis and relationship to ovarian tumors of low malignant potential. Human Pathol 1995; 56: 509-524.
26-Seidman JD, Elsayed AM, Sobin LH, Tavassoli FA. Association of mucinous tumors of the ovary and appendix. A clinicopathologic study of 25 cases. Am J Surg Pathol 1993; 17:22-23.
27-Guerrieri C, Frandlund B, Boeryd B. Expression of cytokeratin 7 in simultaneous mucin tumors of the ovary and appendix. Mod Pathol 1995; 8: 573-576.
28-Ronnet BM, Seidman JD. Mucinous tumors arising in ovarian mature cystic teratomas. Relatioship to the clinical syndrome of pseudomyxoma peritonei. Am J Surg Pathol 2003; 27: 650-657.
29-Lee KR, Scully R. Mucinous tumors of the ovary: a clinicopathologic study of 196 borderline tumors ( of intestinal type ) and carcinomas, including an evaluation of 11 cases with psudomyxoma peritonei. Am J Surg Pathol 2000; 24: 1447-1464.
30-Merino MJ, Edmonds P, LiVolsi V. Appendiceal carcinoma metastatic to the ovaries and mimicking primary ovarian tumors. Int J Gynecol Pathol 1985; 4:110-120.
31-Young RH, Hart WR. Metastases from carcinomas of the pancreas simulating primary mucinous tumors of the ovary: a report of seven cases. Am J Surg Pathol 1989; 13: 748-756.
32-Young RH, Scully RE. Ovarian metastases from carcinoma of the gallbladder and extrahepatic bile ducts simulating primary tumors of the ovary: a report of six cases. Inst J Gynecol Pathol 1990; 9: 60-72.
33-Young RH, Hart WR. Metastases from carcinomas of the pancreas simulating primary mucinous tumors of the ovary: a report of seven cases. Am J Surg Pathol 1989; 13: 748-756.
34-Duval JV, Savas L, Banner BF. Expression of cytokeratins 7 and 20 in carcinomas of the extrahepatic biliary tract, pancreas, and gallbladeer. Arch Path Lab Med 2000; 124: 1198-1200.
35-Low JJ, Chew SH, Chew SP, y col. A rare case of metastatic ovarian carcinoma originating from primary intrahepatic cholangiocarcinoma: case report. Eur J Gynecol Oncol 2003; 24: 85-88.
36- Goldstein NS, Bassi D, Uzieblo A. WT1 is an integral component of an antibody panel to distinguish pancreaticobiliary and some ovarian epithelial neoplasms. Am J Clin Pathol 2001; 116: 246-252.
37-Hashi A, Yuminamochi T, Murata SI, y col. Wilms Tumor Gene immunoreactivity in primary serous carcinomas of the Fallopian tube, ovary, endometrium and peritoneum. Int J Gynecol Pathol 2003; 22: 374-377.
38-Kurman RJ, Seidman JD,Shih I-M. Expert opinion. Serous borderline tumours of the ovary. Histopathol 2005; 47:310-318.
39-Worsley SD, Ponder BA, Davies BR. Overexpression of ciclin D1 in epithelial ovarian cancers. Gynecol Oncol 2005; 29:218-224.
40-Singer G, Stohr R, Cope L y col. Patters of p53 mutations separate ovarian serous borderline tumours and low-and high-grade carcinomas and provide support for a new model of ovarian carcinogenesis:a mutational analysis with immunohistochemical correlation. Am J Surg Pathol 2005; 29: 218-224.
41-Vang R, Gown AM, Barry TS, Wheeler DT, Ronnett BM. Ovarian atypical proliferative (borderline) mucinous tumors: gastrointestinal and seromucinous (endocervical-like) types are immunophenotypically distinctive. Inst J Gynecol Pathol 2005; 25: 83-89.
42-Ronnett BM, Kajdacsy-Balla A, Gilks CB, y col. Mucinous borderline ovarian tumors: points of general agreement and persistent controversies regarding nomenclature, diagnostic criteria, and behavior. Hum Pathol 2004; 35: 949-960.
43-Longacre TA, McKenney JK, Tazealaar HD, y col. Ovarian serous tumors of low malignant potential (borderline tumors ):outcome based study of 276 patients with long-term ( +5 year ) follow-up. Am J Surg Pathol 2005; 29: 707-723.
44-Heinrich JK, Bottcher-Luiz F, Andrade LL, y col. Her-2 and cancer antigen 125 evaluation in ovarian borderline tumors by immunohistochemistry and fluorescence in situ hybridization. Int J Gynecol Cancer 2004; 14: 1978-1085.
45-Al-Hussaini M, Stockman A, Foster H, y col. WT-1 assists in distinguishing ovarian from uterine serous carcinoma and distinghishing between serous and endometrioid ovarian carcinoma. Histopathology 2004; 44:109-115.
46-Lee ES, Leong A S-Y, Kim Y-S, Lee J-H, y col. Calretinin, CD34 and a-smooth muscle actin in the identification of peritoneal invasive implants of serous borderline tumors of the ovary. Modern Pathol 2006; 19: 364-372.
47-Young RH, Scully RE. Urothelial and ovarian carcinomas of identical cell types: problems in interpretation. A report of three cases and review of the literature. Int J Gynecol Pathol 1988; 7: 197-211.
48-Riedel I, Czernobilsky B, Lifschitz-Mercer B, y col. Brenner tumors but no trasitional cell carcinoma of the ovary show urothelial differentiation: immunohistochemical staining of urothelial markers, including cytokeratins and uroplakins. Virchow Arch 2001; 438: 181-191.
49-Logani S, Oliva E, Amin MB, y col. Immunoprofile of ovarian tumors with putative transitional cell ( urothelial) differentiation using novel urothelial markers. Histogenetic and diagnostic implications. Am J Surg Pathol 2003; 27: 1434-1441.
50-Ordoñez NG, Mackay B. Brenner tumor of the ovary: a comparative immunohistochemical and ultrastructural study with transitional cell carcinoma of the bladder. Ultrastruct Pathol 2000, 24: 157-167.
51-Zaino RJ, Unger ER, Whitney C. Syncronous carcinomas of the uterine corpus and ovary. Gynecol Oncol 1984; 19: 329-335.
52-Prat J, Matias-Guiu X, Barreto J. Simultaneous carcinoma involving the endometrium and the ovary. A clinicopathologic, immnuohistochemistry and DNA flow cytometric study of 18 cases. Cancer 1991; 65: 2455-2459.
53-McGluggage WG, Wilkinson N. Metastatic neoplasms involving the ovary: a review with an emphasis on morphological and immunohistochemical features. Histopathol 2005; 47: 231-247.
54-Pins MR, Young RH, Crum CP, y col. Cervical squamous carcinoma in situ with intraepithelial extension to the upper genital tract and invasion of tubes and ovaries: report of a case with human papillomavirus analysis. Int J Gynecol Pathol 1997; 16: 272-278.
55-Struewing JP, Hartage P, Wacholder S, y col. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 1997; 336: 1401-1408.
56-Gagnon Y, Tetu B. Ovarian metastases of breast carcinoma. A clinico-pathologic study of 59 cases. Cancer 1989; 64: 892-898.
57-García Tamayo J, Blasco Olaetxea E, Morales A, Molina J, Guzmán Bistoni C, Szurba E, Méndez V. Importancia de la expresión de E-cadherina en el diagnóstico inmunohistoquímico del cáncer de mama. Aceptado para ser publicado en Invest Clin, Ven, 2006.
58-Young RH, Hart WR. Renal cell carcinoma metastatic to the ovary: a report of three cases emphasizing possible confusion with ovarian clear cell carcinoma. Int J Gynecol Pathol 1992; 11: 96-102.
59-Nolan LP, Heatley MK. The value of immunocytochemistry in distinguishing between clear cell carcinoma of the kidney and ovary. Int J Gynecol Pathol 1988; 7: 197-211.
60-Cameron RI, Ashe P, O´Rourke DM, Foster H, McCluggage WG. A panel of immunohistochemical stains assits in the distinction between ovarian and renal clear cell carcinoma. Int J Gynecol Pathol 2003; 3: 272-276.
61-Langer C, Ratschek M, Rehak P, Schips L, Zigeuner R. Steroid hormonones receptor expression in renal cell carcinoma. Immunohistochemical analysis of 182 tumours. J Urol 2004; 171: 611-614.
62-Morales A, Hernández C, García Tamayo J, Blasco Olaetxea E. Importancia del Factor de Transcripción Nuclear Tiroideo (TTF-1) en el diagnóstico de adenocarcinoma metastático. Estudio inmunohistoquímico de 40 casos. En Vitae-Academia Biomédica digital. http://caibco.ucv.ve/caibco/CAIBCO/Vitae/VitaeDiecinueve/ Abril-Junio, 2004.
63-Young RH, Gersell DJ, Clemente PB, Scully RE. Hepatocellular carcinoma metastatic to the ovary: a report of three cases discovered during life with discussion of the differential diagnosis of hepatoid tumors of the ovary. Human Pathol 1992;23: 574-580.
64-Pitman MB, Triratanachat S, Young RH, Oliva E. Hepatocyte paraffin 1 antibody does not distinguish primary ovarian tumors with hepatoid differentiation from metastatic hepatocellular carcinoma. Inst J Gynecol Pathol 2004; 23: 58-64.
65-Young RH, Scully RE. Malignant melanoma metastasic to the ovary: a clinicopathologic analysis of 20 cases. Am J Surg Pathol 1991; 15: 849-860.
66-Vimla N, Kumar L, Thulkar S, Bal S, Dawar R. Primary malignant melanoma in ovarian cystic teratoma. Gynecol Oncol 2001; 82: 380-383.
67- García Tamayo J, Hernández C. Diagnóstico inmunohistoquímico de los tumores malignos de células redondas. En Vitae-Academia Biomédica digital. http://caibco.ucv.ve/caibco/CAIBCO/Vitae/VitaeDiez/Articulos/AnatomiaPatologica/
Enero-marzo 2002 |